ArticleNature medicine2025
Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ScSpTITH: a rank-correlation framework for robust quantification of multi-dimensional tumor heterogeneity.Human genetics · 2026Article
Corrections and comments
- Erratum for
Authors and funding
59 authors.
Johanna Klughammer *Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. klughammer@genzentrum.lmu.de.ORCID http://orcid.org/0000-0002-3628-9278
Daniel L Abravanel *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. daniel_abravanel@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-0129-1618
Åsa Segerstolpe *Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Timothy R Blosser *Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-7739-922X
Yury Goltsev *Baxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4079-7969
Yi CuiDepartment of Media Arts and Sciences, McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Daniel R GoodwinDepartment of Media Arts and Sciences, McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Anubhav SinhaDepartment of Media Arts and Sciences, McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Orr AshenbergKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Michal SlyperKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Sébastien VigneauCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Judit Jané-ValbuenaKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Shahar AlonDepartment of Media Arts and Sciences, McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Chiara CaraccioBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3580-1348
Judy ChenCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Ofir CohenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nicole CullenCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6541-8588
Laura K DelloStrittoCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Danielle DionneKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Janet FilesDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Allison FrangiehCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Karla HelvieCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Melissa E HughesDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Stephanie IngaCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Abhay KanodiaCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Ana LakoCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Colin MacKichanCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Simon MagesKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1447-6811
Noa MorielSchool of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Evan MurrayBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Sara NapolitanoCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Kyleen NguyenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mor NitzanSchool of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID http://orcid.org/0000-0003-0074-9196
Rebecca OrtizCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Miraj PatelCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Kathleen L PfaffCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Caroline B M PorterKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Asaf RotemCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Sarah StraussDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Robert StrasserGene Center and Department of Biochemistry, Ludwig Maximilians Universität München, Munich, Germany.
Aaron R ThornerCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Madison TurnerCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Isaac WakiroCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5248-4823
Julia WaldmanKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Jingyi WuCenter for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
Jorge Gómez Tejeda ZañudoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1092-0068
Diane ZhangBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Nancy U LinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2263-5413
Sara M TolaneyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5940-8671
Eric P WinerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Edward S BoydenDepartment of Media Arts and Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0419-3351
Fei ChenBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2308-3649
Garry P NolanBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Scott J RodigCenter for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Xiaowei ZhuangDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Orit Rozenblatt-RosenKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Bruce E JohnsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Aviv RegevKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. regev.aviv@gene.com.
Nikhil WagleDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wagle.nikhil@gene.com.ORCID http://orcid.org/0000-0003-3332-9438
Funding
Physician Scientist Training in Cancer ResearchT32CA009172 · NCI · DANA-FARBER CANCER INSTITUTE · PI Jennifer R Brown, James A. DeCaprio · 1985 to 2026
$17.1MNCI NIH HHS T32 CA009172
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.